Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

for
Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07276880

Phase 2, Recruiting

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

for
Pneumococcal Immunization, Healthy Volunteers
Location: Syracuse NY, Tampa FL, Spartanburg SC, Simpsonville SC,
Sponsor: Sanofi

Sex: All

Age: 0

Code: NCT07348692

Phase 3, Recruiting

Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

for
Meningococcal Infection
Location: Swiftwater PA
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 0+

Code: NCT04843111

Recruiting

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

for
Healthy Volunteers, Influenza
Location: Charlottesville VA, Rochester NY, Coral Gables FL,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07779408

Phase 1, Phase 2, Recruiting

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07191717

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Pittsburgh PA, Lexington KY, Irvine CA, Duarte CA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07156227

Phase 1, Recruiting

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

for
Pneumococcal Immunization, Healthy Volunteers
Location: Houston TX
Sponsor: Sanofi

Sex: All

Age: 0

Code: NCT06975878

Phase 3, Recruiting
New

Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne

for
Acne
Location: Edmonton, Vancouver
Sponsor: Sanofi

Sex: All

Age: 12 - 17

Code: NCT07756957

Phase 1, Phase 2, Recruiting

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

for
Lymphoma
Location: Nashville TN
Sponsor: Favrille

Sex: All

Age: 18+

Code: NCT00258336

Phase 2, Recruiting

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

for
Covid19
Location: Raleigh NC, Lenexa KS
Sponsor: Meissa Vaccines, Inc.

Sex: All

Age: 18 - 69

Code: NCT04798001

Phase 1, Recruiting

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

for
Respiratory Syncytial Virus Immunization,
Location: Boston MA, Brookline MA, Methuen MA, East Greenwich RI,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07734649

Phase 1, Phase 2, Recruiting

Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD

for
Breast Cancer, Leptomeningeal Disease
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07694986

Phase 2, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

for
Acne
Location: Jacksonville FL, Brandon FL, New Orleans LA, Encino CA
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT07013747

Phase 1, Phase 2, Recruiting

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

for
Melanoma (Skin)
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0+

Code: NCT00085397

Phase 2, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Brighton MA, Marlborough MA, Quebec, Sherbrooke,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase 1, Phase 2, Recruiting

Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection

for
Chronic Hepatitis B
Location: Richmond VA
Sponsor: Vaccine and Gene Therapy Institute, Florida

Sex: All

Age: 18+

Code: NCT02017587

Recruiting

A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Mobile AL
Sponsor: Southern Cancer Center

Sex: Female

Age: 18 - 70+

Code: NCT00715832

Phase 1, Recruiting

Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

for
Chronic Obstructive Pulmonary Disease
Location: Phoenix AZ
Sponsor: Banner Health

Sex: All

Age: 50 - 64

Code: NCT02563184

Recruiting

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

for
Sickle Cell Disease
Location: New Brunswick NJ, Atlanta GA, Omaha NE, Houston TX
Sponsor: Sanofi

Sex: All

Age: 2 - 17

Code: NCT07247188

Phase 3, Recruiting

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

for
SARS-CoV-2
Location: Richmond VA, Decatur GA, Atlanta GA, Gulfport MS,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 0+

Code: NCT06585241

Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial